Fujun Dai

1.0k total citations
27 papers, 811 citations indexed

About

Fujun Dai is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Fujun Dai has authored 27 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Fujun Dai's work include Polyamine Metabolism and Applications (7 papers), Epigenetics and DNA Methylation (6 papers) and Cannabis and Cannabinoid Research (4 papers). Fujun Dai is often cited by papers focused on Polyamine Metabolism and Applications (7 papers), Epigenetics and DNA Methylation (6 papers) and Cannabis and Cannabinoid Research (4 papers). Fujun Dai collaborates with scholars based in China, United States and Hong Kong. Fujun Dai's co-authors include Zhengfang Yi, Mingyao Liu, Songqiang Xie, Chaojie Wang, Yanmin Dong, Dong Zhai, Yajuan Song, Li Lai, Yihua Chen and Binbin Lu and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Fujun Dai

26 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fujun Dai China 16 526 174 135 95 75 27 811
Marco Miceli Italy 24 836 1.6× 277 1.6× 145 1.1× 79 0.8× 76 1.0× 54 1.5k
Y. Amano Japan 18 474 0.9× 195 1.1× 70 0.5× 108 1.1× 22 0.3× 35 814
Heying Pei China 18 427 0.8× 289 1.7× 150 1.1× 83 0.9× 48 0.6× 56 935
Ji Liu China 21 864 1.6× 146 0.8× 137 1.0× 47 0.5× 171 2.3× 68 1.2k
Wen-Wen Huang Taiwan 16 469 0.9× 66 0.4× 78 0.6× 103 1.1× 109 1.5× 19 700
Athena Sudom United States 16 344 0.7× 210 1.2× 83 0.6× 76 0.8× 90 1.2× 21 809
Zhongyuan Xu China 17 253 0.5× 128 0.7× 98 0.7× 30 0.3× 66 0.9× 59 686
Cheng‐Hui Xu China 20 750 1.4× 187 1.1× 56 0.4× 68 0.7× 117 1.6× 41 1.1k
Binbin Lu China 14 547 1.0× 56 0.3× 97 0.7× 36 0.4× 62 0.8× 27 849
Shu Xu United States 19 334 0.6× 323 1.9× 85 0.6× 347 3.7× 63 0.8× 36 1.0k

Countries citing papers authored by Fujun Dai

Since Specialization
Citations

This map shows the geographic impact of Fujun Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujun Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujun Dai more than expected).

Fields of papers citing papers by Fujun Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fujun Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujun Dai. The network helps show where Fujun Dai may publish in the future.

Co-authorship network of co-authors of Fujun Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Fujun Dai. A scholar is included among the top collaborators of Fujun Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fujun Dai. Fujun Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, You, Feifei Yang, Fujun Dai, et al.. (2025). An acyl pyrrole compound 361B promotes angiogenesis and improves hindlimb ischemia recovery. Current Pharmaceutical Analysis. 21(3). 192–202.
2.
Wu, Yalan, Huixia Liu, Kai Li, et al.. (2024). The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects. Cell Death and Disease. 15(6). 455–455. 8 indexed citations
3.
Dai, Fujun, et al.. (2024). Design, Synthesis, and Biological Evaluation of Naphthalimide‐Polyamine Conjugate as a Potential Anti‐Colorectal Cancer Agent. Chemistry & Biodiversity. 22(4). e202401873–e202401873. 1 indexed citations
4.
Wu, Yalan, Yue Cao, Xiaoxuan Ma, et al.. (2023). Activation of endoplasmic reticulum stress by harmine suppresses the growth of esophageal squamous cell carcinoma. Phytotherapy Research. 37(10). 4655–4673. 11 indexed citations
5.
Kuang, Chaoyuan, Jingshan Tong, Manbo Cai, et al.. (2022). Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death. Frontiers in Oncology. 12. 1018775–1018775. 7 indexed citations
6.
Gao, Lei, et al.. (2021). Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis. Phytomedicine. 85. 153530–153530. 18 indexed citations
7.
Li, Jinghua, Tong Wang, Yuxia Wang, et al.. (2021). Design, Synthesis, and Biological Evaluation of Benzo[cd]indol-2(1H)-ones Derivatives as a Lysosome-Targeted Anti-metastatic Agent. Frontiers in Oncology. 11. 733589–733589. 6 indexed citations
8.
Wang, Yuxia, Xiaojuan Xu, Zhiyang Zhang, et al.. (2021). Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone. Cancer Letters. 519. 30–45. 18 indexed citations
9.
Xu, Xiaojuan, Delu Che, Yue Cao, et al.. (2021). Reactive Oxygen Species Mediate 6c-Induced Mitochondrial and Lysosomal Dysfunction, Autophagic Cell Death, and DNA Damage in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 22(20). 10987–10987. 10 indexed citations
10.
Xu, Xiaojuan, Yuan‐Yen Chang, Songqiang Xie, et al.. (2018). Synthesis and biological evaluation of novel asymmetric naphthalene diimide derivatives as anticancer agents depending on ROS generation. MedChemComm. 9(8). 1377–1385. 10 indexed citations
11.
Dai, Fujun, et al.. (2017). Extracellular polyamines-induced proliferation and migration of cancer cells by ODC, SSAT, and Akt1-mediated pathway. Anti-Cancer Drugs. 28(4). 457–464. 32 indexed citations
12.
Li, Meng, Yuxia Wang, Liping Chang, et al.. (2017). Synthesis and biological evaluation of novel alkylated polyamine analogues as potential anticancer agents. European Journal of Medicinal Chemistry. 143. 1732–1743. 18 indexed citations
13.
Dai, Fujun, Lei Gao, Yuan Zhao, Chaojie Wang, & Songqiang Xie. (2016). Farrerol inhibited angiogenesis through Akt/mTOR, Erk and Jak2/Stat3 signal pathway. Phytomedicine. 23(7). 686–693. 31 indexed citations
14.
Li, Jingjie, Tao Zhang, Feifei Yang, et al.. (2015). Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down‐regulating EGFR expression. British Journal of Pharmacology. 172(15). 3817–3830. 12 indexed citations
15.
Zhang, Tao, Yihua Chen, Jingjie Li, et al.. (2014). Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer. Neoplasia. 16(8). 665–677. 35 indexed citations
16.
Gao, Cheng, Fujun Dai, Shihong Peng, et al.. (2014). Synthesis of Novel Heterocyclic Ring‐Fused 18β‐Glycyrrhetinic Acid Derivatives with Antitumor and Antimetastatic Activity. Chemical Biology & Drug Design. 84(2). 223–233. 35 indexed citations
17.
Dai, Fujun, Yihua Chen, Yajuan Song, et al.. (2012). A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells. PLoS ONE. 7(12). e52162–e52162. 70 indexed citations
18.
Zhang, Tao, Jingjie Li, Yanmin Dong, et al.. (2012). Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion. Breast Cancer Research and Treatment. 135(2). 445–458. 86 indexed citations
19.
Song, Yajuan, Fujun Dai, Dong Zhai, et al.. (2012). Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways. Angiogenesis. 15(3). 421–432. 111 indexed citations
20.
Zhang, Xiaoli, Yajuan Song, Yuanyuan Wu, et al.. (2011). Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2‐mediated JAK/STAT3 signaling in endothelial cell. International Journal of Cancer. 129(10). 2502–2511. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Miceli Breakdown of academic impact, for papers by Y. Amano Breakdown of academic impact, for papers by Heying Pei Breakdown of academic impact, for papers by Ji Liu Breakdown of academic impact, for papers by Wen-Wen Huang Breakdown of academic impact, for papers by Athena Sudom Breakdown of academic impact, for papers by Zhongyuan Xu Breakdown of academic impact, for papers by Cheng‐Hui Xu Breakdown of academic impact, for papers by Binbin Lu Breakdown of academic impact, for papers by Shu Xu
Rankless by CCL
2026